You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
ASCO GU Names Abstract Among Four to Be Highlighted During 2014 Meeting SAN FRANCISCO, CA AND NORTHBROOK, Ill. – December 19, 2013 -- Medivation Inc. (NASDAQ: MDVN) and Astellas Pharma Global...
NORTHBROOK, Ill. and SAN DIEGO, Dec. 10, 2013 /PRNewswire/ -- Astellas Pharma Global Development, Inc., a subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), and Vical Incorporated...
San Francisco, CA and Northbrook, IL – December 4, 2013 – Medivation, Inc. (Nasdaq: MDVN) and Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503)...
NORTHBROOK, Ill., Dec. 3, 2013 /PRNewswire/ -- Astellas Pharma US, Inc., a subsidiary of Astellas Pharma Inc. based in Tokyo, Japan, announced today that the U.S. Food and Drug Administration...
Win recognizes outstanding financial and R&D performance as Astellas brings an array of new medicines to market for patients in need NORTHBROOK, Ill., Nov. 22, 2013 /PRNewswire/ -- Astellas US...
Read more about Astellas named 'Company of the Year' at international SCRIP Awards 2013
Follow U.S. news
